KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Other Non-Current Assets (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Other Non-Current Assets for 9 consecutive years, with $287000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Other Non-Current Assets fell 78.04% to $287000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $287000.0, a 78.04% decrease, with the full-year FY2022 number at $1.4 million, down 52.86% from a year prior.
  • Other Non-Current Assets was $287000.0 for Q3 2023 at Palvella Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q4 2020 to a low of $287000.0 in Q3 2023.
  • A 5-year average of $2.2 million and a median of $2.2 million in 2020 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: soared 245.71% in 2019, then crashed 78.04% in 2023.
  • Palvella Therapeutics' Other Non-Current Assets stood at $3.1 million in 2019, then increased by 5.18% to $3.3 million in 2020, then dropped by 12.24% to $2.9 million in 2021, then tumbled by 52.86% to $1.4 million in 2022, then plummeted by 79.04% to $287000.0 in 2023.
  • Per Business Quant, the three most recent readings for PVLA's Other Non-Current Assets are $287000.0 (Q3 2023), $1.1 million (Q2 2023), and $1.3 million (Q1 2023).